Efpia.eu - SEO Checker

Overview of the SEO Check
Meta information
67% 
Page quality
83% 
Page structure
92% 
Link structure
71% 
Server
67% 
External factors
79% 
SEO Score
Response time
0.08 s
File size
89.70 kB
Words
591
Media files
12
Number of links
101 internal / 19 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
EFPIA Homepage
The page title is too short. (160 pixels of 580 max pixel length) Optimize title
There are no duplicate words in the title
Meta description
(Critically important)
The meta description is empty.
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
No canonical link is specified.
Language
(Somewhat important)
Language detected in text: en
Server location: United States of America
The language is not specified in the HTML markup.
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width, initial-scale=1
keywordsEmpty
descriptionEmpty
msapplication-config/favicon/browserconfig.xml
theme-color#ffffff
og:titleEFPIA Homepage
og:typewebsite
og:urlhttp://efpia.eu/
Content-Typetext/html;charset=UTF-8
encodingutf-8
X-UA-CompatibleIE=edge
AuthorEFPIA EU
X-Content-Type-Optionsnosniff
X-Frame-OptionsSAMEORIGIN
X-X-XSS-Protection: 1Empty
charsetutf-8

Automatically check efpia.eu including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Page quality

Content
(Critically important)
The average number of words per sentence of 30.4 words is high.
This page contains 591 words. That's ok.
24.4% of the text are stop words.
Words from the H1 heading are used in the page content.
The page contains a listing, which indicates a good text layout.
7 paragraphs were found on this page.
The text content is perfect.
No placeholders texts or images were found.
There are no duplicates on the site.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
This page loads 6 JavaScript files. This may affect the load time negatively.
A viewport "width=device-width, initial-scale=1" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 12 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
The HTTPS protocol for secure data transmission is not used.

Page structure

H1 heading
(Critically important)
Europe's Choice
The H1 heading is too short (15 characters). It should be at least 20 Characters long.
Headings
(Important)
Some headings do not have any content.

Heading structure

Heading levelContent
H1 Europe's Choice
H2 Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
H2 Latest Updates
H2 Featured Articles
H2 Empty heading
H3 EFPIA Statement on the EU–Mercosur Free Trade Agreement
H3 EFPIA statement following European Parliament plenary vote on the Critical Medicines Act
H3 From readiness to reality: preparing Europe for the next phase of Alzheimer’s care
H3 Health Economics and Policy Evaluation Course March 2026
H3 2nd European Summit for Women Leaders in Life Sciences
H3 DIA Europe 2026
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 19 external links on this page.
LinkAttributesAnchor text
http://efpia.eu/Home
http://efpia.eu/europes-choice/Europe's Choice
http://efpia.eu/Anchor News & Events chevron_right
http://efpia.eu/Anchor About medicines chevron_right
http://efpia.eu/Anchor More Than Medicine chevron_right
/pharmaceutical-legislation/Pharmaceutical Legislation
http://efpia.eu/Anchor Relationships & code chevron_right
http://efpia.eu/Anchor Publications chevron_right
http://efpia.eu/Anchor About us chevron_right
http://efpia.eu/contact-us/Contact us
http://kms.efpia.eu/user/login...New window External Subdomain KMS Login
http://efpia.eu/europes-choice/Text duplicate Europe's Choice
http://efpia.eu/news-events/News & Events
/news-events/the-efpia-view/The EFPIA View
/news-events/events/Events
/news-events/newsletter/Newsletter
http://efpia.eu/about-medicines/About medicines
/about-medicines/development-o...Development of medicines expand_more expand_less chevron_right
/about-medicines/development-o...Animal Use and Welfare
/about-medicines/development-o...Antimicrobial resistance (AMR)
/about-medicines/development-o...Digital Health
/about-medicines/development-o...Intellectual Property
/about-medicines/development-o...Precision medicine
/about-medicines/development-o...Public-private partnerships
/about-medicines/development-o...Regulations, safety & supply
/about-medicines/development-o...SMEs in Europe
/about-medicines/development-o...Trade
/about-medicines/development-o...Unmet medical need
/about-medicines/use-of-medici...Use of medicines expand_more expand_less chevron_right
/about-medicines/use-of-medici...HTA & Relative Efficacy Assessment
/about-medicines/use-of-medici...Disease-specific groups
/about-medicines/use-of-medici...Healthcare Systems
/about-medicines/use-of-medici...Value of medicines
/about-medicines/access-to-med...Access to medicines expand_more expand_less chevron_right
/about-medicines/access-to-med...Back Innovation, Boost Access
/more-than-medicine/More Than Medicine
/more-than-medicine/improving-...Improving Health
/more-than-medicine/turning-sc...Turning science into new medicines
/more-than-medicine/responsibl...Responsible Innovation
/more-than-medicine/economic-i...Economic impact
/pharmaceutical-legislation/Text duplicate Pharmaceutical Legislation
/relationships-code/Relationships & code
/relationships-code/the-efpia-...The EFPIA Code
/relationships-code/patient-or...Patient organisations
/relationships-code/healthcare...Healthcare professionals (HCPs)
/relationships-code/disclosure...Disclosure of payments
/relationships-code/national-c...National codes
/relationships-code/eu-institu...EU institutions
http://efpia.eu/publications/Publications
/publications/data-center/Data center
/publications/downloads/Downloads
/publications/cancer-comparato...Cancer Comparator Report 2025 expand_more expand_less chevron_right
/publications/cancer-comparato...Recommendations
/publications/cancer-comparato...Cancer Cases
/publications/cancer-comparato...Cancer Deaths
/publications/cancer-comparato...Survival
/publications/cancer-comparato...Cancer Care
http://efpia.eu/about-us/About us
/about-us/who-we-are/Who we are
/about-us/efpia-japan/EFPIA Japan
/about-us/membership/Membership
/about-us/job-vacancies/Job vacancies
/about-us/partnerships-initiat...Partnerships & Initiatives
http://efpia.eu/contact-us/Text duplicate Contact us
/about-medicines/development-o...Development of medicines
/about-medicines/development-o...Text duplicate Animal Use and Welfare
/about-medicines/development-o...Text duplicate Antimicrobial resistance (AMR)
/about-medicines/development-o...Text duplicate Digital Health
/about-medicines/development-o...Text duplicate Intellectual Property
/about-medicines/development-o...Text duplicate Precision medicine
/about-medicines/development-o...Text duplicate Public-private partnerships
/about-medicines/development-o...Text duplicate Regulations, safety & supply
/about-medicines/development-o...Text duplicate SMEs in Europe
/about-medicines/development-o...Text duplicate Trade
/about-medicines/development-o...Text duplicate Unmet medical need
/about-medicines/use-of-medici...Use of medicines
/about-medicines/use-of-medici...Text duplicate HTA & Relative Efficacy Assessment
/about-medicines/use-of-medici...Text duplicate Disease-specific groups
/about-medicines/use-of-medici...Text duplicate Healthcare Systems
/about-medicines/use-of-medici...Text duplicate Value of medicines
/about-medicines/access-to-med...Access to medicines
/about-medicines/access-to-med...Text duplicate Back Innovation, Boost Access
/publications/cancer-comparato...Cancer Comparator Report 2025
/publications/cancer-comparato...Text duplicate Recommendations
/publications/cancer-comparato...Text duplicate Cancer Cases
/publications/cancer-comparato...Text duplicate Cancer Deaths
/publications/cancer-comparato...Text duplicate Survival
/publications/cancer-comparato...Text duplicate Cancer Care
http://efpia.eu/No Text
http://efpia.eu/europes-choice/New window LEARN MORE
/pharmaceutical-legislation/Text duplicate LEARN MORE
/a-strategy-for-european-life-...Text duplicate LEARN MORE
/relationships-code/the-efpia-...Text duplicate LEARN MORE
http://efpia.eu/news-events/VIEW ALL
/news-events/the-efpia-view/st...Statements & press releases 20.01.26 EFPIA Statement on the EU–Mercosur Free Trade Agreement While the agreement includes some progress for the innovative ph...
/news-events/the-efpia-view/st...Statements & press releases 20.01.26 EFPIA statement following European Parliament plenary vote on the Critical Medicines Act EFPIA acknowledges today’s vote...
/news-events/the-efpia-view/bl...Blog articles 20.01.26 From readiness to reality: preparing Europe for the next phase of Alzheimer’s care Europe has reached a turning point on Alzheimer’s d...
/news-events/events/external-e...External Event 02.03.26 Health Economics and Policy Evaluation Course March 2026 Join the Health Economics and Policy Evaluation ONLINE Course 2026, delivere...
/news-events/events/external-e...External Event 10.03.26 2nd European Summit for Women Leaders in Life Sciences Get ready for C5’s 2nd Annual European Summit for Women Leaders in Life Scienc...
/news-events/events/external-e...External Event 24.03.26 DIA Europe 2026 Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver bett...
http://www.vaccineseurope.eu/External Subdomain IMG-ALT Vaccines Europe
http://www.imi.europa.eu/External Subdomain IMG-ALT IMI Europe
https://www.ethicalmedtech.eu/...External Subdomain IMG-ALT 4 Ethics
https://www.emvo-medicines.eu/External Subdomain IMG-ALT EMVO
http://www.ich.org/External Subdomain IMG-ALT ICH
https://www.ihi.europa.eu/External Subdomain IMG-ALT IHI
http://efpia.eu/privacy-notice/Privacy Policy
https://www.youtube.com/channe...New window External Subdomain No Text
https://twitter.com/efpiaNew window External No Text
https://www.linkedin.com/compa...New window External Subdomain No Text
http://www.vaccineseurope.eu/External Subdomain Text duplicate IMG-ALT Vaccines Europe
http://www.imi.europa.eu/External Subdomain Text duplicate IMG-ALT IMI Europe
https://www.ethicalmedtech.eu/...External Subdomain Text duplicate IMG-ALT 4 Ethics
https://www.emvo-medicines.eu/External Subdomain Text duplicate IMG-ALT EMVO
http://www.ich.org/External Subdomain Text duplicate IMG-ALT ICH
https://www.ihi.europa.eu/External Subdomain Text duplicate IMG-ALT IHI
https://www.youtube.com/channe...New window External Subdomain No Text
https://twitter.com/efpiaNew window External No Text
https://www.linkedin.com/compa...New window External Subdomain No Text
http://efpia.eu/privacy-notice/Disclaimer

Server configuration

HTTP redirects
(Critically important)
The checked page does not redirect to another URL.
HTTP header
(Important)
The web server version is sent within the HTTP header.
The X-powered header is sent within the response header. (unnecessary)
The web server transmits the web page (HTML) in compressed form.
Performance
(Somewhat important)
This page loads 7 CSS files. This may affect the page load time negatively.
This page loads 6 JavaScript files. This may affect the load time negatively.
The page response time is excellent with 0.08 seconds.
The file size of the HTML document is fine (90 kB).

HTTP Response Header

NameValue
transfer-encodingchunked
content-typetext/html; charset=utf-8
content-encodinggzip
varyAccept-Encoding
serverMicrosoft-IIS/10.0
access-control-allow-origin*
x-powered-byASP.NET
dateWed, 21 Jan 2026 08:55:39 GMT
statuscode200
http_versionHTTP/1.1

External factors

This page has only a few links from other websites.
This page only has backlinks from 18 referring domains.
This page only has 636 backlinks.
This page only has few backlinks from 18 different ip addresses.
This page is referenced by wikipedia.

Search preview

efpia.eu
EFPIA Homepage

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
EFPIA70%Check
Europe60%Check
EFPIA Statement59%Check
EFPIA Code56%Check
Choice55%Check
Europe 202654%Check
life47%Check
sciences47%Check
European47%Check
Life Sciences47%Check

Automatically check efpia.eu including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions